MD2850F1 - Method of inducing the medicamental abortion - Google Patents

Method of inducing the medicamental abortion Download PDF

Info

Publication number
MD2850F1
MD2850F1 MDA20050046A MD20050046A MD2850F1 MD 2850 F1 MD2850 F1 MD 2850F1 MD A20050046 A MDA20050046 A MD A20050046A MD 20050046 A MD20050046 A MD 20050046A MD 2850 F1 MD2850 F1 MD 2850F1
Authority
MD
Moldova
Prior art keywords
medicamental
abortion
inducing
hours
izoturon
Prior art date
Application number
MDA20050046A
Other languages
Romanian (ro)
Other versions
MD2850G2 (en
Inventor
Valentin FRIPTU
Victor GHICAVII
Ludmila FRIPTU
Mihail Todiras
Ecaterina Stratu
Corina Cardaniuc
Original Assignee
Valentin FRIPTU
Victor GHICAVII
Ludmila FRIPTU
Mihail Todiras
Ecaterina Stratu
Corina Cardaniuc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentin FRIPTU, Victor GHICAVII, Ludmila FRIPTU, Mihail Todiras, Ecaterina Stratu, Corina Cardaniuc filed Critical Valentin FRIPTU
Priority to MDA20050046A priority Critical patent/MD2850G2/en
Publication of MD2850F1 publication Critical patent/MD2850F1/en
Publication of MD2850G2 publication Critical patent/MD2850G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la obstetrica si ginecologie si poate fi utilizata pentru intreruperea sarcinii la termene mici si anume pana la 56 zile, asociate cu amenoree. Esenta inventiei consta in aceea ca se administreaza per os 200 mg de mifepriston, apoi, peste 24...48 de ore, se administreaza de patru ori intravaginal peste fiecare 6 ore cate un supozitor, care contine 50 mg de bromura de S-etilizotiouroniu (izoturon).The invention relates to medicine, especially obstetrics and gynecology, and can be used for pregnancy termination, ie up to 56 days, associated with amenorrhea. The essence of the invention consists in the fact that 200 mg of mifepristone is administered per bone, then, over 24 ... 48 hours, it is given four times intravaginally every 6 hours as one suppository, which contains 50 mg of S-ethylisothiourium bromide. (Izoturon).

MDA20050046A 2005-02-18 2005-02-18 Method of inducing the medicamental abortion MD2850G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Publications (2)

Publication Number Publication Date
MD2850F1 true MD2850F1 (en) 2005-09-30
MD2850G2 MD2850G2 (en) 2006-07-31

Family

ID=35057541

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050046A MD2850G2 (en) 2005-02-18 2005-02-18 Method of inducing the medicamental abortion

Country Status (1)

Country Link
MD (1) MD2850G2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20070283A (en) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Process for charging current formation for a capacitive energy storage system
MD215Z (en) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Capacitive storage charger
MD281Z (en) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Adjustable resonant voltage converter
MD4073C1 (en) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Stabilized high-voltage converter

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263C2 (en) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ "Isoturon" means with antihypotensive activity
MD1223C2 (en) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies
MD2228G2 (en) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD2323G2 (en) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MD2491G2 (en) * 2004-02-10 2005-01-31 Виктор ГИКАВЫЙ Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20070283A (en) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Process for charging current formation for a capacitive energy storage system
MD215Z (en) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Capacitive storage charger
MD4073C1 (en) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Stabilized high-voltage converter
MD281Z (en) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Adjustable resonant voltage converter

Also Published As

Publication number Publication date
MD2850G2 (en) 2006-07-31

Similar Documents

Publication Publication Date Title
CL2008002207A1 (en) Pharmaceutical composition comprising immunosuppressants to improve the effect in the use of an antagonist of interleukin-6 (il-6) for the treatment of illnesses related to il-6 (div. Sol. 896-04).
DE60045394D1 (en) COMPOSITIONS AGAINST INFECTIONS FOR TREATMENT RESULT IN TISSUE SUCH AS FOR EXAMPLE. FEVER BUBBLES
PT1261367E (en) UTILIZATION OF INTERLEUKIN 6 ANTAGONISTS FOR THE TREATMENT OF ESTROGEN DEPENDENT TUMORS
AR109461A2 (en) FORMULATION OF ANTI-CD20 ANTIBODY AND ITS USE TO PREPARE A MEDICINAL PRODUCT
MA28182A1 (en) CLASS C OLIGONUCLEOTIDE ANALOGUES HAVING INCREASED IMMUNOSTIMULATORY PROPERTIES
TR201900764T4 (en) Compositions containing LAG-3 and therapeutic antibodies and their use in cancer therapy.
ATE429210T1 (en) ORAL LIQUID COMPOSITIONS
HUP0303720A2 (en) Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol
AR053651A1 (en) COMBINED TREATMENT OF ANTIBODY ANTICTLA4 R AROMATASE INHIBITOR FOR BREAST CANCER
CL2015002899A1 (en) Pharmaceutical composition of stable topical ointment and suitable excipient selected from white wax, white soft paraffin and mixtures thereof. (divisional application 848-2011).
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
BRPI0517799A (en) composition to facilitate human childbirth
PE20091693A1 (en) PROTEASE-ACTIVATED RECEPTOR 2 ANTAGONIST
SE0300098D0 (en) Use of cyclin D1 inhibitors
Ferreira et al. Avaliação da ação antimicrobiana de diferentes medicações usadas em endodontia
MD2850F1 (en) Method of inducing the medicamental abortion
PE20050665A1 (en) SELECTIVE ESTROGENS OF 8ß-VINYL-ESTRA-1,3,5 (10) -TRIEN-3,17ß-DIOL AND 17ß-FLUOR-9-VINYL-ESTRA-1,3,6 (10) -TRIEN-3,16ALPHA -DIOL
GB2407504A (en) Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
HUP0401634A2 (en) Use of lhrh-antagonists in doses that do not cause castration for the improvement of t-cell mediated immunity and for preparation of pharmaceutical compositions
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
MD2323F1 (en) Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
EA201000097A1 (en) 8-BETA-SUBSTITUTED ESTRATRIENES AS A SELECTIVE ACTIVE STROGEN
TR200103398T2 (en) Substituted phenylcyclohexanecarboxamides and their use as inhibitors of adenosine intake
MD2053C2 (en) Remedy with interferon inducing action
ES2421598T3 (en) Glucopeptide composition with improved antibiotic activity

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees